SCHEMBL19486154

SCHEMBL19486154

C=C(C)/C=C/CC(C)CCN=CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7782876 0.76 ALDH1A1 (0.41)
SCHEMBL7782877 0.76 ALDH1A1 (0.41)
SCHEMBL11350586 0.71
SCHEMBL11350589 0.71
SCHEMBL8530818 0.68
SCHEMBL1958323 0.68
SCHEMBL31033482 0.68 ALDH1A1 (0.37)
SCHEMBL6135683 0.68 ALOX15 (0.50)
SCHEMBL6135686 0.68 ALOX15 (0.50)
SCHEMBL14243154 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10889815-B2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) SIRNA THERAPEUTICS, INC. (US) 2021-01-12 US disclosed
US-10662428-B2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) SIRNA THERAPEUTICS, INC. (US) 2020-05-26 US disclosed
US-20190233821-A1 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) BANK OF AMERICA, N.A. 2019-08-01 US disclosed
US-20190194658-A1 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) SIRNA THERAPEUTICS, INC. 2019-06-27 US disclosed
US-20170298355-A1 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) BANK OF AMERICA, N.A. 2017-10-19 US disclosed